BioSpace News Archive

Neuro Rehab VR announces its XR Therapy System, the first clinically validated and FDA registered VR therapy system for neurological rehabilitation and physical therapy treatment and assessment in clinical environments.

Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that its leadership will present at the Jefferies Virtual Global Healthcare Conference on November 17-19. In one-on-one sessions, the Company will present its corporate overview for fiscal year 2021 with a special focus on multiple growth opportunities driven by advances in the

Third-Line Cohort Added to Phase 2 Pancreatic Cancer Trial for Combination Immunotherapy That Includes Aldoxorubicin, ImmunityBio’s N-803 and NantKwest’s PD-L1 t-haNK Three Trial Sites in California and South Dakota Will Initially Enroll 298 Patients Across the Cohorts, With 40 Patients Already Enrolled or Being Evaluated LOS ANGELES--( BUSINESS WIRE )-- CytRx Corporation (OTCQB:CYTR) (“CytRx” or the “Company”), a specialized biopharmaceuti

Halberd Corporation reported that Arizona State University researchers, utilizing the intellectual property of Halberd Corporation, have successfully generated an anti-Spike protein monoclonal antibody against Covid-19.

--First compound from pipeline of six early-stage oncology programs to advance into clinical development-- --Company anticipates initiating Phase 1/2 clinical trial of NUV-422 by Q1 2021-- [13-October-2020] NEW YORK , Oct. 13, 2020 /PRNewswire/ -- Nuvation Bio, Inc. , an oncology company focused on revolutionizing cancer treatment by discovering, developing

Immersion Corporation (NASDAQ: IMMR), the leading developer and provider of technologies for haptics, today announced its support for the ANA Avatar XPRIZE – a competition challenging teams to develop a physical Avatar System that will transport an operator’s senses

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that it was awarded the Society for Clinical Research Sites (SCRS) Eagle Award, sweeping the CRO category for the fourth consecutive year.

Jaguar Has Closed on the First $6 Million Tranche of the Previously Announced Non-Dilutive Royalty Financing Transaction - Which Now Has the Potential to Total $17 Million

A new brief released by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute shows that counterfeit drugs put patients in harm’s way, hinder drug innovation, and lead to job losses.

Georgia School of Orthodontics has awarded four additional Atlanta based children with complimentary orthodontic care through its Gift of a Smile program.